FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称UMBRALISIB
异名/同义词2-((1S)-1-(4-AMINO-3-(3-FLUORO-4-(1-METHYLETHOXY)PHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)ETHYL)-6-FLUORO-3-(3-FLUOROPHENYL)-4H-1-BENZOPYRAN-4-ONE
4H-1-BENZOPYRAN-4-ONE, 2-((1S)-1-(4-AMINO-3-(3-FLUORO-4-(1-METHYLETHOXY)PHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)ETHYL)-6-FLUORO-3-(3-FLUOROPHENYL)-
RP5264
RP-5264
TGR-1202
TGR-1202 FREE BASE
UMBRALISIB
UMBRALISIB [INN]
UMBRALISIB [USAN]
UMBRALISIB [WHO-DD]
CAS登记号1532533-67-7
物质唯一标识(Unique Ingredient Identifier)38073MQB2A
分子式C31H24F3N5O3
国际化合物标识(International Chemical Identifier,InChI)IUVCFHHAEHNCFT-INIZCTEOSA-N
SMILESc1(cc2c(cc1)oc(c(c2=O)-c3cc(ccc3)F)[C@@H](n4nc(c5c4ncnc5N)-c6ccc(c(c6)F)OC(C)C)C)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System